文献速递儿科与产科急症重症综合管理与镇静镇痛心脑血管急症

儿童心肌炎体外膜氧合插管时机:体外生命支持组织登记处的探索性分析

Extracorporeal Membrane Oxygenation Cannulation Timing in the Pediatric Myocarditis Population: An Exploratory Analysis From the Extracorporeal Life Support Organization Registry.
PubMed 文献 · Crit Care Explor · 2022-12-30
一句话结论儿童心肌炎ECMO患者总体生存率72%;未发生心脏骤停者插管前插管时间≥18小时与生存率降低相关(校正OR 0.09)。

该研究回顾性分析了体外生命支持组织登记处2007至2018年间≤18岁因心肌炎接受ECMO支持的506例索引运行。主要终点为出院生存率,按ECMO前是否发生心脏骤停及插管后至ECMO插管时间分层。总体生存率为72%,2007-2012年与2013-2018年两个时期无差异(p=0.69)。存活者ECMO前pH更高,插管至插管时间更短(3小时[IQR 1-14] vs 6小时[IQR 2-20],p=0.021)。54%(n=273)的ECMO运行在插管前24小时内发生心脏骤停(包括体外心肺复苏)。在未发生心脏骤停的患者中,插管至插管时间≥18小时与较低生存率相关(校正OR 0.09,IQR 0.02-0.40,p=0.002)。作者认为,未发生心脏骤停的儿童心肌炎患者若在插管后早期接受ECMO插管,可能获得更好的生存结局。

要点

  • 儿童心肌炎ECMO总体出院生存率为72%,2007-2012年与2013-2018年两个时期无差异(p=0.69)。
  • 存活者插管至ECMO插管时间更短(3小时[IQR 1-14] vs 6小时[IQR 2-20],p=0.021),ECMO前pH更高。
  • 54%(n=273)的ECMO运行在插管前24小时内发生心脏骤停(包括体外心肺复苏)。
  • 未发生心脏骤停的患者中,插管至插管时间≥18小时与较低生存率相关(校正OR 0.09,IQR 0.02-0.40,p=0.002)。
  • 作者认为,未发生心脏骤停的儿童心肌炎患者插管后早期ECMO插管可能改善生存。

适用人群与场景

  • ≤18岁因心肌炎接受ECMO支持的患者,数据来自体外生命支持组织登记处2007-2018年。
  • 排除非索引运行、非静脉-动脉ECMO或主要研究变量数据缺失者。

研究设计与关键结果

  • 回顾性分析国际登记处数据,纳入506例儿童心肌炎索引ECMO运行,主要终点为出院生存率。
  • 总体生存率为72%,2007-2012年与2013-2018年两个时期无差异(p=0.69)。
  • 存活者ECMO前pH更高,插管至插管时间更短(3小时[IQR 1-14] vs 6小时[IQR 2-20],p=0.021)。
  • 54%(n=273)的ECMO运行在插管前24小时内发生心脏骤停(包括体外心肺复苏)。
  • 在校正ECMO前心脏骤停与插管至插管时间的交互作用后,未发生心脏骤停的患者中,插管至插管时间≥18小时与较低生存率相关(校正OR 0.09,IQR 0.02-0.40,p=0.002)。

证据类型、等级与局限

  • 证据类型:回顾性登记处分析(探索性分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,接近ECMO插管且未发生心脏骤停的儿童心肌炎患者,若在插管后早期接受ECMO插管,可能获得更好的生存结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Children presenting with acute myocarditis may experience rapid clinical deterioration requiring extracorporeal membrane oxygenation (ECMO); however, our understanding of best practices and timing of ECMO initiation are lacking. We explored the relationships between pre-cannulation factors and survival in this high-acuity patient population.

DESIGN: Retrospective review of a large international registry. Primary outcome was survival to hospital discharge, stratified by incident cardiac arrest (CA) prior to ECMO and time to cannulation after intubation.

SETTING AND SUBJECTS: The Extracorporeal Life Support Organization registry was queried for patients less than or equal to 18 years old receiving ECMO support for myocarditis between 2007 and 2018. Exclusion criteria included being nonindex runs, non-venoarterial ECMO or missing data points for main variables studied.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Population characteristics and survival were compared using t test, Wilcoxon rank-sum test, or Fisher exact test. Multivariable logistic regression was used for significant factors in the unadjusted logistic regression. Among 506 index ECMO runs in pediatric patients with myocarditis, survival for the cohort was 72%, with no difference between early and late eras (2007-2012 vs 2013-2018; p = 0.69). Survivors demonstrated higher pre-ECMO pH levels as well as shorter intubation-to-cannulation (ITC) times (3 hr [interquartile range (IQR)], 1-14 hr vs 6 hr [IQR, 2-20 hr]; p = 0.021). CA occurred within 24 hours prior to ECMO cannulation, including extracorporeal cardiopulmonary resuscitation, in 54% of ECMO runs (n = 273). Accounting for the interaction between pre-ECMO CA occurrence and ITC time, longer ITC time remained associated with lower survival for patients who did not experience a CA prior to ECMO, with adjusted odds ratio of 0.09 (IQR, 0.02-0.40; p = 0.002) for ITC time greater than or equal to 18 hours.

CONCLUSIONS: The results of this multicenter analysis of ECMO utilization and outcomes for pediatric myocarditis suggest that patients approaching ECMO cannulation who have not experienced CA may have better survival outcomes if cannulated onto ECMO early after intubation.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Gutierrez ME, Anders M, Guffey D, et al. Extracorporeal Membrane Oxygenation Cannulation Timing in the Pediatric Myocarditis Population: An Exploratory Analysis From the Extracorporeal Life Support Organization Registry. Crit Care Explor. 2022. PMID: 36619364. doi:10.1097/CCE.0000000000000826

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。